The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Calidi intends to use ...

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative cancer medicines, today announced that it has entered into ...

Glucot (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the launch of a “best efforts” ...

Orchestrating intelligent agent flows: The Dayforce platform smoothly coordinates ... Annual Reports on Form 10-K and other reports we file with the Securities and Exchange Commission. Copies of ...

Acrivon Therapeutics, Inc. ("Acrivon” or "Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage precision medicine company ...

2023 and other periodic reports filed by Tharimmune from time to time with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent ...

Nov. 12, 2024 (GLOBE NEWSWIRE) -- Setting a new standard in transfer agent services ... statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities ...

Investors Title Company is engaged in the business of issuing and underwriting title insurance policies. The Company also provides services in connection with tax-deferred exchanges of like-kind ...

After securing the approval of the Securities and Exchange Commission, DoubleDragon Corp. has started its P10-billion bond ...

Analyst forecasts $110K Bitcoin price, BlackRock sees $1 billion in daily inflows into spot Bitcoin ETF, and more: Hodler's Digest ...

Detailed price information for Fuelcell Energy Inc (FCEL-Q) from The Globe and Mail including charting and trades.